Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2005 Mar 8;19(2):87–92. doi: 10.1002/jcla.20057

Distribution of oxidation enzyme eNOS and myeloperoxidase in primary open angle glaucoma

Hui‐Ju Lin 1,2,3, Chang‐Hai Tsai 2, Fuu‐Jen Tsai 2, Wei‐Cheng Chen 2, Shih‐Wei Tsai 4,, Seng‐Sheen Fan 3
PMCID: PMC6808135  PMID: 15756709

Abstract

Genetic factors and the influence of superoxide are known to play roles in the etiology of glaucoma. We evaluated the association between primary open angle glaucoma (POAG) and two polymorphisms in the epithelial nitric oxide synthase (eNOS) gene, and one polymorphism in the myeloperoxidase (MPO) gene. We enrolled 66 patients with POAG and 100 healthy volunteers in this study. The polymorphisms in the eNOS and the polymorphism MPO −463 G‐to‐A in the MPO gene were resolved by polymorphism polymerase chain reaction (PCR). There were no significant differences in the distribution of the eNOS intron −4 (P=0.481), eNOS promotor −786 (P=0.555), and MPO −463 (P=0.292) gene polymorphisms between the POAG patients and the volunteers (P‐values=0.481, 0.555, and 0.292, respectively). None of the alleles from either gene differed between the groups (P‐values=0.483, 0.554, and 0.183, respectively). Superoxide is closely related to glaucoma, and eNOS and MPO are two important enzymes in the free radical pathway. However, polymorphisms of the eNOS intron‐4, eNOS promotor −786, and MPO −463 gene polymorphisms did not reveal significant differences between POAG patients and controls in our study. The use of these agents and other superoxide‐related genes for clinical applications requires further investigation. J. Clin. Lab. Anal. 19:87–92, 2005. © 2005 Wiley‐Liss, Inc.

Keywords: endothelial nitric oxide synthase (eNOS), free radicals, myeloperoxidase (MPO), oxidation, primary open angle glaucoma (POAG)

REFERENCES

  • 1. Anderson RE, Rapp LM, Wiegand RD. Lipid peroxidation and retinal degeneration. Curr Eye Res 1984;3:223–227. [DOI] [PubMed] [Google Scholar]
  • 2. Ko ML, Hu DN, Ritch R, Sharma SC. The combined effect of brain‐derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest Ophthalmol Vis Sci 2000;41:2967–2971. [PubMed] [Google Scholar]
  • 3. Beckman J, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol 1994;233:229–240. [DOI] [PubMed] [Google Scholar]
  • 4. Eiserich JP, Cross CE, Jones AD, Halliwell B, van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. J Biol Chem 1996;271:. [DOI] [PubMed] [Google Scholar]
  • 5. Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 1994;14:5147–5159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Bredt DS, Snyder SH. Nitric oxide, a physiological messenger molecule. Ann Rev Biochem 1994;63:175–195. [DOI] [PubMed] [Google Scholar]
  • 7. Koss MC. Functional role of nitric oxide in regulation of ocular blood flow. Eur J Pharmacol 1999;374:161–174. [DOI] [PubMed] [Google Scholar]
  • 8. Lam TT, Tso MO. Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats. Res Commun Mol Pathol Pharmacol 1996;92:329–340. [PubMed] [Google Scholar]
  • 9. Ostwald P, Goldstein IM, Pachnanda A, Roth S. Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci 1995;36:2396–2403. [PubMed] [Google Scholar]
  • 10. Dimmeler S, Zeiher AM. Nitric oxide and apoptosis: another paradigm for the double‐edged role of nitric oxide. Nitric Oxide 1997;1:275–281. [DOI] [PubMed] [Google Scholar]
  • 11. van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase‐catalyzed oxidation of nitrite. J Biol Chem 1997;272: [DOI] [PubMed] [Google Scholar]
  • 12. Eiserich JP, Hristova M, Cross CE, et al. Formation of nitric oxide‐derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391: [DOI] [PubMed] [Google Scholar]
  • 13. Harman D. Free radical theory of aging. Mutat Res 1992;275:257–266. [DOI] [PubMed] [Google Scholar]
  • 14. Siu AW, Reiter RJ, To CH. The efficacy of vitamin E and melatonin as antioxidants against lipid peroxidation in rat retinal homogenates. J Pineal Res 1998;24:239–244. [DOI] [PubMed] [Google Scholar]
  • 15. Siu AW, Reiter RJ, To CH. Pineal indoleamines and vitamin E reduce nitric oxide‐induced lipid peroxidation in rat retinal homogenates. J Pineal Res 1999;27:122–128. [DOI] [PubMed] [Google Scholar]
  • 16. Nakayama M, Yasue H, Yoshimura M, et al. T‐786 → C Mutation in the 5′‐flanking region of the endothelial nitric oxide synthase gene is associated with organic stenosis. Am J Cardiol 2000;86:628–634. [DOI] [PubMed] [Google Scholar]
  • 17. Pecoits‐Filho R, Stenvinkel P, Marchlewska A, et al. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end‐stage renal disease patients. Kidney Int Suppl 2003;63:S172–S176. [DOI] [PubMed] [Google Scholar]
  • 18. Becquet F, Courtois Y, Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv Ophthalmol 1997;42:71–82. [DOI] [PubMed] [Google Scholar]
  • 19. Schmetterer L, Krejcy K, Kastner J, et al. The effect of systemic nitric oxidesynthase inhibition on ocular fundus pulsations in man. Exp Eye Res 1997;64:305–312. [DOI] [PubMed] [Google Scholar]
  • 20. Nathanson JA. Nitric oxide and nitrovasodilators in the eye: implication for ocular physiology and glaucoma. J Glaucoma 1993;2:206–210. [PubMed] [Google Scholar]
  • 21. Nathanson JA, McKee M. Identification of an extensive system of nitric oxide‐producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci 1995;36:1765–1773. [PubMed] [Google Scholar]
  • 22. Hangai M, Miyamoto K, Hiroi K, et al. Roles of constitutive nitric oxide synthase in postischemic rat retina. Invest Ophthalmol Vis Sci 1999;40:450–458. [PubMed] [Google Scholar]
  • 23. Nathanson JA, McKee M. Alterations of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci 1995;36:1774–1784. [PubMed] [Google Scholar]
  • 24. Kurosaki R, Muramatsu Y, Michimata M, et al. Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol Res 2002;24:655–662. [DOI] [PubMed] [Google Scholar]
  • 25. Chang CJ, Chiang CH, Chow JC, Lu DW. Aqueous humor nitric oxide levels differ in patients with different types of glaucoma. J Ocul Pharmacol Ther 2000;5:399–406. [DOI] [PubMed] [Google Scholar]
  • 26. Oku H, Yamaguchi H, Sugiyama T, Kojima S, Ota M, Azuma I. Retinal toxicity of nitric oxide released by administration of a nitric oxide donor in the albino rabbit. Invest Ophthalmol Vis Sci 1997;38:2540–2544. [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES